Delivery Order SPE2DE22D0008-SPE2D625F0DS1
- Not listed
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, and quality control materials to various U.S. government agencies. The contract, valued at $22,621.60, is a delivery order for "ALBACLONE ANTI-D BLEND" products. It is a firm fixed-price contract with a period of performance ending on...
- This contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order for $14,457.00 with Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various U.S. government agencies. The contract is for the delivery of ALBACLONE Anti-A products and has a completion date of September 5, 2024. This contract is not designated as a set-aside. Alba...
- This federal contract award to Alba Bioscience, Inc., a subsidiary of Quotient Biodiagnostics, Inc., is for the delivery of ALBACLONE anti-B medical supplies. The $3,792.00 Firm Fixed Price contract was awarded on May 16, 2025 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of May 21, 2025. The contract is not designated as a set-aside. Alba Bioscience, Inc. is a for-profit organization specializing in in vitro diagnostics, blood bank reagents, and other...
- This federal contract award to Alba Bioscience, Inc., a foreign-owned for-profit organization, is for the delivery of ALBACLONE Anti-A blood typing reagents to the Defense Logistics Agency (DLA) Troop Support Medical. The $3,555.00 firm-fixed-price contract has a period of performance through June 13, 2024 and was awarded on June 10, 2024. Alba Bioscience, a subsidiary of Quotient Biodiagnostics, Inc., is a leading supplier of specialized blood banking products and services to federal...
- Alba Bioscience, Inc. received a $2,030 firm fixed-price delivery order from the Department of Defense's Medical Supply Chain on June 5, 2025, for the ALBACYTE Antibody ID Panel (16-Cell). The contract, which carries an ultimate completion date of August 11, 2025, was awarded without a set-aside designation, reflecting Alba Bioscience's competitive standing as a supplier of specialized in vitro diagnostic products. Performance will take place in Chicago, Illinois, where the vendor maintains...
- This federal contract award, with ID SPE2DE22D0008|SPE2D625F1414, was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in in vitro diagnostics, blood bank reagents, and quality control materials. The contract, with a ceiling value of $1,118.00, is for the delivery of "ALBACLONE ANTI-A" products, which are likely blood typing reagents or antibodies used in blood banking operations. The contract is a Delivery...
- This is a federal contract award to Alba Bioscience, Inc., a for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various federal agencies. The contract, awarded by the Defense Logistics Agency (DLA) Medical Supply Chain, is for the delivery of ALBACLONE Anti-A blood banking products with a ceiling value of $1,118.00. The contract is a Firm Fixed Price Delivery Order and has an ultimate...
- This federal contract award with ID SPE2DE22D0008|SPE2D625F23XA was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Alba Bioscience, Inc., a for-profit organization and subsidiary of Quotient Biodiagnostics, Inc. The $22,550.00 firm fixed-price contract is for the delivery of ALBACLONE Anti-D Blend products, which are specialized blood banking reagents and diagnostic materials used for blood typing and transfusion services in federal healthcare facilities. The contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a subsidiary of Quotient Biodiagnostics, Inc. The contract is for the delivery of ALBACYTE antibody identification panels, which are in vitro diagnostic products used in blood banking operations across various government agencies, including the Department of Veterans Affairs (VA), Defense Health Agency (DHA), and National Institutes of Health (NIH). The contract is a Delivery Order with a Firm...
- This federal contract award SPE2DE22D0008|SPE2D625F22W7 was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization specializing in in vitro diagnostics, blood bank reagents, and quality control materials. The $5,160.00 firm fixed-price delivery order contract is for the provision of ALBACYTE antibody identification panels, a critical product supporting blood banking operations across federal healthcare systems. Alba Bioscience, a...
- SPE2DE22D0008Indefinite Delivery Contract
- SPE2DE22D0008-SPE2D625F0DS1Delivery Order
The Defense Logistics Agency, operating under the Defense or Civilian designation, awarded a delivery order contract (4568409675) to Alba Bioscience, Inc. on June 2, 2025, for the supply of ALBACLONE Anti-K antibodies. The contract represents a firm fixed price delivery order with a ceiling value of $15,944.00 and an ultimate completion date of June 5, 2025. The award was made on a non-set-aside basis, reflecting Alba Bioscience's competitive standing as an established supplier of specialized blood bank reagents and in vitro diagnostic products. Performance will be executed at the company's facility located in Chicago, Illinois. Alba Bioscience, Inc., a foreign-owned subsidiary of Quotient Biodiagnostics, Inc., specializes in the production and distribution of critical blood banking supplies and antibody screening materials for federal healthcare systems. The company maintains two significant Blanket Purchase Agreements with the Department of Veterans Affairs under General Services Administration Schedule 65-VII, with combined ceiling values exceeding $309,000 through various expiration dates. This delivery order for ALBACLONE Anti-K antibodies aligns with the company's established role as a primary supplier of immunohematology reagents and blood typing products to federal agencies, including the Defense Logistics Agency, Veterans Affairs, and the National Institutes of Health.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.9k | 6/2/25 |